Hospital News
Clinical Services
Return to Myasthenia Gravis Overview
More on Myasthenia Gravis
- ALS (Lou Gehrig's Disease)
- Aneurysm
- Ataxia
- Behcet's Disease
- Dystonia
- Guillain-Barre Syndrome
- Huntington's Disease
- Movement Disorders
- Myoclonus
- Myopathy
- Neurology and Neuroscience
- Neuromuscular Diseases
- Neuropathy
- Neuro-sarcoidosis
- Research for Brain Aneurysms
- Symptoms of Brain Aneurysms
- Tourette's Syndrome
- Treatment of Brain Aneurysms
- Tremor
- Vasculitis
Neurology and Neuroscience
Myasthenia Gravis
Back to the nypneuro.org Home Page
About Myasthenia Gravis
Myasthenia gravis (MG) is a rare autoimmune disease in which the immune system interferes with the transmission of nerve impulses to the muscles. People with myasthenia gravis develop severe, sometimes life-threatening, weakness. Patients benefit from the care of physicians who have extensive experience treating myasthenia gravis.
Medical Treatment for Myasthenia Gravis
Doctors have several treatment options for controlling myasthenia gravis.
Surgical Treatment for Myasthenia Gravis
The thymus, an immune-system organ under the breast bone, is implicated in the development of myasthenia gravis, but its role is not well understood. Doctors often treat myasthenia gravis by removing the thymus (a procedure called a thymectomy). Symptoms improve in as many as 70 percent of patients who have undergone thymectomy, and it may lead to a cure in some of these patients. These improvements may occur months to years after surgery. Thymectomy is most effective in those under age 60 and early in the course of the disease.
Research for Myasthenia Gravis
Researchers at NewYork-Presbyterian/Columbia are participating in clinical studies to define the most effective role of thymectomy in myasthenia gravis treatment.



